BMRN logo

BioMarin Pharmaceutical (BMRN) Income Tax

Annual Income Tax

$20.92 M
+$12.90 M+160.99%

December 31, 2023

Summary

Performance

1-Year Change

+160.99%

3-Year Change

+102.32%

5-Year Change

+131.94%

15-Year Change

-74.23%

BMRN Income Tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.15%
BMRN annual income tax is higher than 85.15% of companies in Healthcare sector

High & Low

All-time High

$81.17 M
BMRN annual income tax is currently -74.23% below its historical high of $81.17 million

3-Year Low

-$11.27 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BMRN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 19, 2025
BMRN next annual earnings announcement is scheduled for Feb 19, 2025

OtherBMRNexpensesmetrics:

Annual Total Expenses

$2.26 B
BMRN annual total expenses is $2.26 billion

Annual Operating Expenses

$1.75 B
BMRN annual total operating expenses is $1.75 billion

Annual Cost Of Goods Sold

$514.85 M
BMRN annual cost of goods sold is $514.85 million

Annual Interest Expense

$16.74 M
BMRN annual interest expense is $16.74 million

Quarterly Income Tax

$28.36 M
+$3.40 M+13.62%

September 30, 2024

Summary

Performance

3-Month Change

+13.62%

1-Year Change

+2806.2%

3-Year Change

+380.29%

5-Year Change

+380.29%

BMRN Quarterly Income Tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

90.81%
BMRN quarterly income tax is higher than 90.81% of companies in Healthcare sector

High & Low

All-time High

$105.99 M
BMRN quarterly income tax is currently -73.24% below its historical high of $105.99 million

3-Year Low

-$17.31 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BMRN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 19, 2025
BMRN next earnings announcement is scheduled for Feb 19, 2025

OtherBMRNexpensesmetrics:

Quarterly Total Expenses

$631.85 M
BMRN quarterly total expenses is $631.85 million

Quarterly Operating Expenses

$443.39 M
BMRN quarterly total operating expenses is $443.39 million

Quarterly Cost Of Goods Sold

$188.46 M
BMRN quarterly cost of goods sold is $188.46 million

Quarterly Interest Expense

$2.97 M
BMRN quarterly interest expense is $2.97 million

TTM Income Tax

$69.16 M
+$27.07 M+64.31%

September 30, 2024

Summary

Performance

3-Month Change

+64.31%

1-Year Change

+230.62%

3-Year Change

+12924.48%

5-Year Change

+12924.48%

BMRN TTM Income Tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.21%
BMRN TTM income tax is higher than 89.21% of companies in Healthcare sector

High & Low

All-time High

$82.53 M
BMRN TTM income tax is currently -16.20% below its historical high of $82.53 million

3-Year Low

-$11.27 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BMRN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 19, 2025
BMRN next earnings announcement is scheduled for Feb 19, 2025

OtherBMRNexpensesmetrics:

Annual Total Expenses

$2.26 B
BMRN annual total expenses is $2.26 billion

Annual Operating Expenses

$1.75 B
BMRN annual total operating expenses is $1.75 billion

TTM Cost Of Goods Sold

$564.82 M
BMRN TTM cost of goods sold is $564.82 million

TTM Interest Expense

$15.59 M
BMRN TTM interest expense is $15.59 million

Income Tax Formula

Income Tax Expense = Current Tax Expense + Deferred Tax Expense

BMRN Income Tax Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+161.0%+2806.2%+230.6%
3 y3 years+102.3%+380.3%+10000.0%
5 y5 years+131.9%+380.3%+10000.0%

BMRN Income Tax Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+285.6%at high+263.9%at high+713.7%
5 y5-yearat high+102.3%at high+103.3%at high+107.5%
alltimeall time-74.2%+102.3%-73.2%+103.3%-16.2%+107.5%

BioMarin Pharmaceutical Income Tax History

DateAnnualQuarterlyTTM
Sep 2024
-
$28.36 M(+13.6%)
$69.16 M(+64.3%)
Jun 2024
-
$24.96 M(+47.8%)
$42.09 M(+32.0%)
Mar 2024
-
$16.89 M(-1711.2%)
$31.90 M(+52.5%)
Dec 2023
$20.92 M(+161.0%)
-$1.05 M(-181.2%)
$20.92 M(+349.2%)
Sep 2023
-
$1.29 M(-91.3%)
$4.66 M(-42.6%)
Jun 2023
-
$14.77 M(+150.1%)
$8.11 M(+1428.1%)
Mar 2023
-
$5.91 M(-134.1%)
$531.00 K(-93.4%)
Dec 2022
$8.02 M(-171.1%)
-$17.31 M(-464.6%)
$8.02 M(-51.9%)
Sep 2022
-
$4.75 M(-33.9%)
$16.65 M(+645.2%)
Jun 2022
-
$7.19 M(-46.3%)
$2.23 M(-159.8%)
Mar 2022
-
$13.39 M(-254.3%)
-$3.74 M(-66.8%)
Dec 2021
-$11.27 M(-98.8%)
-$8.68 M(-10.2%)
-$11.27 M(-83.0%)
Sep 2021
-
-$9.67 M(-895.6%)
-$66.48 M(-92.6%)
Jun 2021
-
$1.22 M(-79.3%)
-$902.84 M(-1.6%)
Mar 2021
-
$5.86 M(-109.2%)
-$917.14 M(+1.6%)
Dec 2020
-$903.03 M(+1172.5%)
-$63.89 M(-92.4%)
-$903.03 M(+4.5%)
Sep 2020
-
-$846.02 M(+6363.1%)
-$863.94 M(+1268.3%)
Jun 2020
-
-$13.09 M(-165.5%)
-$63.14 M(+15.8%)
Mar 2020
-
$19.97 M(-180.5%)
-$54.51 M(-23.2%)
Dec 2019
-$70.96 M(+8.4%)
-$24.80 M(-45.1%)
-$70.96 M(-17.3%)
Sep 2019
-
-$45.21 M(+913.8%)
-$85.82 M(+81.1%)
Jun 2019
-
-$4.46 M(-226.8%)
-$47.40 M(-14.3%)
Mar 2019
-
$3.52 M(-108.9%)
-$55.32 M(-15.5%)
Dec 2018
-$65.49 M(-180.7%)
-$39.66 M(+483.9%)
-$65.49 M(-181.7%)
Sep 2018
-
-$6.79 M(-45.2%)
$80.16 M(+1.6%)
Jun 2018
-
-$12.38 M(+86.1%)
$78.86 M(-4.4%)
Mar 2018
-
-$6.66 M(-106.3%)
$82.53 M(+1.7%)
Dec 2017
$81.17 M(-140.4%)
$105.99 M(-1409.5%)
$81.17 M(-409.0%)
Sep 2017
-
-$8.09 M(-7.1%)
-$26.27 M(-44.8%)
Jun 2017
-
-$8.71 M(+8.7%)
-$47.56 M(-76.5%)
Mar 2017
-
-$8.02 M(+454.4%)
-$202.78 M(+1.0%)
Dec 2016
-$200.84 M(-1276.2%)
-$1.45 M(-95.1%)
-$200.84 M(+14.7%)
Sep 2016
-
-$29.39 M(-82.1%)
-$175.05 M(+20.6%)
Jun 2016
-
-$163.93 M(+2598.5%)
-$145.18 M(-897.6%)
Mar 2016
-
-$6.08 M(-125.0%)
$18.20 M(+6.6%)
DateAnnualQuarterlyTTM
Dec 2015
$17.07 M(+87.6%)
$24.35 M(+4941.0%)
$17.07 M(-631.4%)
Sep 2015
-
$483.00 K(-187.2%)
-$3.21 M(-59.4%)
Jun 2015
-
-$554.00 K(-92.3%)
-$7.92 M(+397.5%)
Mar 2015
-
-$7.20 M(-277.4%)
-$1.59 M(-117.5%)
Dec 2014
$9.10 M(-6167.3%)
$4.06 M(-196.1%)
$9.10 M(+18.9%)
Sep 2014
-
-$4.22 M(-173.2%)
$7.66 M(-39.2%)
Jun 2014
-
$5.77 M(+65.4%)
$12.58 M(+56.3%)
Mar 2014
-
$3.49 M(+33.5%)
$8.05 M(-5468.0%)
Dec 2013
-$150.00 K(-96.2%)
$2.62 M(+271.4%)
-$150.00 K(-198.0%)
Sep 2013
-
$704.00 K(-43.3%)
$153.00 K(-102.2%)
Jun 2013
-
$1.24 M(-126.4%)
-$6.96 M(-19.2%)
Mar 2013
-
-$4.71 M(-261.4%)
-$8.61 M(+119.0%)
Dec 2012
-$3.93 M(-138.5%)
$2.92 M(-145.6%)
-$3.93 M(+21.7%)
Sep 2012
-
-$6.40 M(+1458.2%)
-$3.23 M(-394.7%)
Jun 2012
-
-$411.00 K(+1108.8%)
$1.10 M(-79.7%)
Mar 2012
-
-$34.00 K(-100.9%)
$5.41 M(-47.0%)
Dec 2011
$10.21 M(-104.5%)
$3.62 M(-274.2%)
$10.21 M(-2324.2%)
Sep 2011
-
-$2.08 M(-153.2%)
-$459.00 K(-99.8%)
Jun 2011
-
$3.90 M(-18.1%)
-$220.33 M(-1.3%)
Mar 2011
-
$4.76 M(-167.6%)
-$223.18 M(-1.8%)
Dec 2010
-$227.31 M(<-9900.0%)
-$7.05 M(-96.8%)
-$227.31 M(+2.8%)
Sep 2010
-
-$221.95 M(<-9900.0%)
-$221.09 M(<-9900.0%)
Jun 2010
-
$1.06 M(+66.0%)
$1.81 M(+41.9%)
Mar 2010
-
$636.00 K(-176.6%)
$1.27 M(+20.8%)
Dec 2009
$1.05 M(-59.4%)
-$830.00 K(-187.8%)
$1.05 M(-73.2%)
Sep 2009
-
$945.00 K(+81.0%)
$3.93 M(+21.4%)
Jun 2009
-
$522.00 K(+25.2%)
$3.24 M(+12.8%)
Mar 2009
-
$417.00 K(-79.7%)
$2.87 M(+10.8%)
Dec 2008
$2.59 M(+255.7%)
$2.05 M(+713.5%)
$2.59 M(+270.4%)
Sep 2008
-
$252.00 K(+64.7%)
$700.00 K(+9.4%)
Jun 2008
-
$153.00 K(+10.9%)
$640.00 K(+31.4%)
Mar 2008
-
$138.00 K(-12.1%)
$487.00 K(+29.9%)
Dec 2007
$729.00 K
$157.00 K(-18.2%)
$375.00 K(+72.0%)
Sep 2007
-
$192.00 K(+638.5%)
$218.00 K(+738.5%)
Mar 2007
-
$26.00 K
$26.00 K

FAQ

  • What is BioMarin Pharmaceutical annual income tax?
  • What is the all time high annual income tax for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical annual income tax year-on-year change?
  • What is BioMarin Pharmaceutical quarterly income tax?
  • What is the all time high quarterly income tax for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical quarterly income tax year-on-year change?
  • What is BioMarin Pharmaceutical TTM income tax?
  • What is the all time high TTM income tax for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical TTM income tax year-on-year change?

What is BioMarin Pharmaceutical annual income tax?

The current annual income tax of BMRN is $20.92 M

What is the all time high annual income tax for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high annual income tax is $81.17 M

What is BioMarin Pharmaceutical annual income tax year-on-year change?

Over the past year, BMRN annual income tax has changed by +$12.90 M (+160.99%)

What is BioMarin Pharmaceutical quarterly income tax?

The current quarterly income tax of BMRN is $28.36 M

What is the all time high quarterly income tax for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high quarterly income tax is $105.99 M

What is BioMarin Pharmaceutical quarterly income tax year-on-year change?

Over the past year, BMRN quarterly income tax has changed by +$29.41 M (+2806.20%)

What is BioMarin Pharmaceutical TTM income tax?

The current TTM income tax of BMRN is $69.16 M

What is the all time high TTM income tax for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high TTM income tax is $82.53 M

What is BioMarin Pharmaceutical TTM income tax year-on-year change?

Over the past year, BMRN TTM income tax has changed by +$48.24 M (+230.62%)